Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

280

Citations

25

References

2012

Year

Anna Maria Di Giacomo, Paolo A. Ascierto, Lorenzo Pilla, Mario Santinami, Pier Francesco Ferrucci, Diana Giannarelli, Antonella Marasco, Licia Rivoltini, Ester Simeone, Stefania VL Nicoletti,

The Lancet Oncology

OncologySingle-arm Phase 2MelanomaImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentMedicineRadiation OncologyAdvanced Melanoma

References

	Year	Citations

Page 1

Page 1